Normal Pressure Hydrocephalus Clinical Trials

6 recruiting

Normal Pressure Hydrocephalus Trials at a Glance

12 actively recruiting trials for normal pressure hydrocephalus are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Beijing, Buenos Aires, and Bologna. Lead sponsors running normal pressure hydrocephalus studies include CereVasc Inc, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, and Beijing Tiantan Hospital.

Browse normal pressure hydrocephalus trials by phase

Treatments under study

About Normal Pressure Hydrocephalus Clinical Trials

Looking for clinical trials for Normal Pressure Hydrocephalus? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Normal Pressure Hydrocephalus trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Normal Pressure Hydrocephalus clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting

European Study of Prodromal iNPH

HydrocephalusNormal Pressure Hydrocephalus
Johan Virhammar140 enrolled7 locationsNCT05910944
Recruiting
Not Applicable

Multi-omics Research of Idopathic Normal Pressure Hydrocephalus (iNPH)

Idiopathic Normal Pressure Hydrocephalus
Second Affiliated Hospital, School of Medicine, Zhejiang University40 enrolled1 locationNCT04998175
Recruiting
Not Applicable

Normal Pressure Hydrocephalus and Sleep Apnea

Sleep ApneaNormal Pressure HydrocephalusCerebrospinal Fluid Shunt Occlusion
University of Valencia30 enrolled1 locationNCT04471740
Recruiting

White Matter Distortion and Dementia Biomarkers in Normal Pressure Hydrocephalus (NPH)

Normal Pressure Hydrocephalus
Imperial College London100 enrolled1 locationNCT07103681
Recruiting

Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)

Parkinson's DiseaseParkinsonismFreezing of Gait+2 more
Tianjin Huanhu Hospital700 enrolled1 locationNCT07386015
Recruiting
Not Applicable

Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

Normal Pressure Hydrocephalus
CereVasc Inc230 enrolled30 locationsNCT06498960
Recruiting

Integrated Multimodal Assessment to Optimize Diagnosis and Surgical Selection in Idiopathic Normal Pressure Hydrocephalus

Idiopathic Normal Pressure Hydrocephalus
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico116 enrolled2 locationsNCT07427836
Recruiting
Not Applicable

Endoscopic Third Ventriculostomy vs. Ventriculoperitoneal Shunt in Idiopathic Normal Pressure Hydrocephalus (ENDOVEST)

Idiopathic Normal Pressure Hydrocephalus (INPH)
University Hospital, Basel, Switzerland150 enrolled1 locationNCT06488248
Recruiting

Proteinopathies Expression in Skin of Neurodegenerative Disorders

Amyotrophic Lateral SclerosisAlzheimer DiseaseParkinson Disease+3 more
Universidad Autonoma de San Luis Potosí40 enrolled1 locationNCT06528964
Recruiting

Identifying Gait Changes From a CSF Tap Test Using a Smart Insole in iNPH

Normal Pressure Hydrocephalus
Yonsei University50 enrolled1 locationNCT06722768
Recruiting
Phase 2

The Safety and Efficacy of Rapamycin on Communicating Hydrocephalus Secondary to Intraventricular Hemorrhage

Communicating HydrocephalusCerebral Intraventricular HemorrhageSecondary Normal Pressure Hydrocephalus+1 more
Beijing Tiantan Hospital53 enrolled1 locationNCT06563817
Recruiting

Clinical Outcome in Patients With INPH

HydrocephalusIdiopathic Normal Pressure HydrocephalusCSF+2 more
Xuanwu Hospital, Beijing200 enrolled1 locationNCT06428734